NeuoKaire develops a personalized medical testing tool that employs biomarker analysis to create tailored treatment plans for individuals with depression. This method enhances treatment efficacy by pinpointing specific biological factors that influence each patient's mental health condition.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Psychiatric and neurological disorders are often treated with a trial-and-error approach due to the complex and heterogeneous nature of these conditions. This can lead to delays in finding effective treatments, exposing patients to unnecessary side effects and prolonged suffering. Current diagnostic methods often lack the precision needed to personalize treatment plans based on individual patient biology.
Solution
NeuroKaire offers a precision medicine platform that uses a patient's own cells to predict their response to different treatments for psychiatric and neurological disorders. The platform begins by converting a patient's blood cells into induced pluripotent stem cell (iPSC)-derived neurons. These neurons are then exposed to various compounds, and their responses are analyzed using computer vision and deep learning algorithms. The resulting data is combined with the patient's clinical and demographic information to generate a personalized prediction of drug efficacy, enabling clinicians to make more informed treatment decisions.
Target Audience
The primary target audience includes clinicians in psychiatry and neurology, biopharmaceutical companies developing CNS therapies, and patients seeking personalized treatment options for psychiatric and neurological disorders.
Features
- Generation of iPSC-derived neurons from patient blood samples using Nobel-Prize winning technology.
- Exposure of patient-derived neurons to various compounds to assess drug response.
- Analysis of neuronal function, activity, and communication using computer vision and deep learning.
- Integration of neuronal response data with patient clinical and demographic information.
- AI-powered prediction of individual drug efficacy for personalized treatment planning.
- Comprehensive data repository combining imaging, genomic, and clinical data from patient-derived neurons.